Loading clinical trials...
Loading clinical trials...
The Effect of an Ondansetron on Blood Coagulation: In Vitro, Volunteer Study Using Rotational Thromboelastometry
Ondansetron may alter whole blood coagulation. However, little is known about the dose-response relationships according to the blood concentration of ondansetron. The investigators therefore will perform the present study to measure the effect of ondansestron on the blood coagulation pathway according to the drug concentration level using a thromboelastography test.
Age
20 - 65 years
Sex
ALL
Healthy Volunteers
Yes
Seoul National Univ. Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Start Date
September 16, 2020
Primary Completion Date
November 15, 2023
Completion Date
December 15, 2023
Last Updated
March 15, 2023
12
ESTIMATED participants
0 ul of ondansetron
DRUG
0.2 ul of ondansetron
DRUG
2 ul of ondansetron
DRUG
20 ul of ondansetron
DRUG
Lead Sponsor
Seoul National University Bundang Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT03734588